(Press-News.org) Contact information: Kimberley Wang
kimberley.wang@nus.edu.sg
65-660-11653
National University of Singapore
Latest research findings offer potential new treatments for acute myeloid leukemia
2 separate studies yield key findings for the prevention, diagnosis, treatment and cure for the disease
Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.
Both research teams, comprising international scientists from Singapore, United States, Austria, Italy, Netherlands, United Kingdom and Sweden and the Czech Republic, were led by Professor Daniel Tenen, Director, Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS).
Breakthrough study validates Sox4 as potential therapeutic target
In this breakthrough study, the researchers discovered, for the first time, a molecular target for CEBPA mutations by demonstrating that targeting Sox4 effectively perturbs the major leukemogenic phenotypes in human patient samples of mutated CEBPA AML. These findings were first published in the leading scientific journal Cancer Cell on 11 November 2013.
Although CEBPA mutations have been studied for decades, the precise oncogenic pathway and the role of their downstream targets are still poorly understood. This is the first study that identified a molecular target downstream of CEBPA mutations. By identifying the failure to suppress oncogene Sox4 expression as the underlying mechanism of CEBPA mutant-transformed leukemia stem cells (LSCs), the study highlights Sox4 as a potential therapeutic target for a subtype of AML. The discovery provides a direct route for the treatment of such leukemia and is a big step forward as there are currently limited therapeutic options for this subtype of AML.
Moving forward, the researchers intend to continue investigating the downstream signaling components of Sox4 during normal hematopoiesis and leukemogenesis. Based on the findings of Sox4 as a crucial node in mutated CEBPA-driven leukemogenesis, the team will focus on identifying its downstream signaling components and explore whether inhibition of these pathways, using pharmaceutical drugs, can effectively eradiate LSCs. They will also look into the development of novel therapeutic drugs for cancer.
New research identifies histone deacetylase inhibitors as potential candidates in treatment of AML
In the second study, the scientists identified a group of genes which were not properly expressed in a subgroup of AML patient samples. They demonstrated that HDAC inhibitors were able to reactivate expression of these genes and as such, could potentially be used as drugs in the treatment of certain AML. The discovery was first published online in the scientific journal Haematologica on 31 October 2013.
The research team examined the blood samples of more than 500 patients who were newly diagnosed with AML for this study. They found that a group of genes, known as the CEBPA signature, was not properly expressed in 20 per cent of the blood samples. Their findings also revealed that the CEBPA signature was responsible for blocking the growth of granulocytes, impeding their ability to mature into healthy blood cells.
The scientists further tested the effects of HDAC inhibitors, a class of anti-cancer drugs that trigger the production of proteins, on the subtype of AML using laboratory models and blood samples from patients. They found that the HDAC inhibitors were able to reactivate the expression of the CEBPA signature and promote the growth of healthy blood cells, demonstrating the HDAC inhibitors as potential drug targets for the treatment of the AML subtype.
As HDAC inhibitors have complex mechanisms of action, the research team intends to further examine how they behave at the molecular level in order to establish ways to promote the growth of healthy blood cells.
Said Professor Daniel Tenen, "Up to now, therapeutic options for AML are very limited. By understanding oncogenic pathways and the signatures which respond to specific enzyme inhibitors, we can build up our knowledge and understanding towards the development of more efficient drugs. We hope to apply similar approaches to identify new therapeutic avenues for other types of AML."
### END
Latest research findings offer potential new treatments for acute myeloid leukemia
2 separate studies yield key findings for the prevention, diagnosis, treatment and cure for the disease
2013-11-25
ELSE PRESS RELEASES FROM THIS DATE:
Human neural stem cells could meet the clinical problem of critical limb ischemia
2013-11-25
Human neural stem cells could meet the clinical problem of critical limb ischemia
New research has shown human neural stem cells could improve blood flow in critical limb ischemia through the growth of new vessels. Critical limb ischemia (CLI) is a disease ...
UEF study determines reference values for children's heart rate variability
2013-11-25
UEF study determines reference values for children's heart rate variability
Measurement of heart rate variability (HRV) is a useful method when assessing the role of the nervous system for heart function. Standard reference values for ...
Dying from a food allergy is less likely than being murdered
2013-11-25
Dying from a food allergy is less likely than being murdered
A person with a food allergy is more likely to be murdered than to die from a severe reaction, according to a new study.
One in 10 children has a food allergy. Many sufferers and their parents experience ...
Companies that screen social media accounts alienate job candidates
2013-11-25
Companies that screen social media accounts alienate job candidates
Research from North Carolina State University shows companies that screen the social media accounts of job applicants alienate potential employees – making it harder for them to attract ...
Researchers describe 1 mechanism that favors rejection in transplantation of porcine cartilage in humans
2013-11-25
Researchers describe 1 mechanism that favors rejection in transplantation of porcine cartilage in humans
Inhibition of the complement system protects the transplant of pig cartilage cells
Researchers at the Bellvitge Institute of Biomedical ...
Researchers use nanoscale 'patches' to sensitize targeted cell receptors
2013-11-25
Researchers use nanoscale 'patches' to sensitize targeted cell receptors
Researchers from North Carolina State University and Duke University have developed nanoscale "patches" that can be used to sensitize targeted cell receptors, making them more responsive ...
New immunotherapy for malignant brain tumors
2013-11-25
New immunotherapy for malignant brain tumors
This news release is available in German. Animal experiments show that it is relatively easy to treat cancer in the early stages. However, it is far more difficult to successfully treat advanced cancer. ...
Breastfeeding provides babies with iodine
2013-11-25
Breastfeeding provides babies with iodine
This news release is available in German. Iodine is essential for the human body. This trace element is especially crucial for infants in order to ensure healthy development. Iodine deficiency can disrupt growth ...
Coumarins show potency as anti-inflammatory drugs
2013-11-25
Coumarins show potency as anti-inflammatory drugs
New methods for the laboratory-scale synthesis of coumarin-based drugs were developed in a recent study completed at the University of Eastern Finland. In his doctoral thesis, Lic. Phil. Juri Timonen also developed new ...
Teens 'eat more, cheat more' after playing violent video games
2013-11-25
Teens 'eat more, cheat more' after playing violent video games
Research finds effects go beyond increase in aggression
COLUMBUS, Ohio – Playing violent video games not only increases aggression, it also leads to less self-control and more cheating, a new study finds.
Researchers ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Latest research findings offer potential new treatments for acute myeloid leukemia2 separate studies yield key findings for the prevention, diagnosis, treatment and cure for the disease